ACAMPROSATE-AN ANTI-CRAVING DRUG FOR ALCOHOL USE DISORDER (AUD) PHARMACOTHERAPY: PLASMA METABOLOMICS SIGNATURES ARE ASSOCIATED WITH ALCOHOL CRAVING INTENSITY AND ACAMPROSATE TREATMENT RESPONSE.

被引：0
|
作者：
Ho, M. [1 ]
Zhang, C. [1 ]
Zhang, L. [1 ]
Moon, I. [1 ]
Geske, J. [1 ]
Choi, D. [1 ]
Biernacka, J. [1 ]
Oesterle, T. [1 ]
Frye, M. [1 ]
Seppala, M. [2 ]
Li, H. [1 ]
Karpyak, V. [1 ]
Weinshilboum, R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Hazelden Betty Ford Fdn, Center City, MN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-042
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 23 条
  • [1] Acamprosate-an Anti-Craving Drug for Alcohol Use Disorder (AUD) Pharmacotherapy: Plasma Metabolomics Signatures are Associated With Alcohol Craving Intensity and Acamprosate Treatment Response
    Ho, Ming-Fen
    Zhang, Cheng
    Zhang, Lingxin
    Moon, Irene
    Geske, Jennifer
    Choi, Doo-Sup
    Biernacka, Joanna
    Oesterle, Tyler
    Frye, Mark
    Seppala, Marvin
    Li, Hu
    Karpyak, Victor
    Weinshilboum, Richard
    [J]. BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S139 - S140
  • [2] POTENTIAL MECHANISMS OF ACTION OF THE ANTI-CRAVING DRUG, ACAMPROSATE, IN ALCOHOL DEPENDENCE
    BOUCHENAFA, O
    ELQATARI, M
    KHAN, S
    LITTLETON, JM
    [J]. BEHAVIOURAL PHARMACOLOGY, 1995, 6 (5-6): : 614 - 614
  • [3] Role of Acamprosate and Baclofen as Anti-craving Agents in Alcohol Use Disorder: A 12-Week Prospective Study
    Sharma, Akhilesh K.
    Rikhari, Praveen
    Shukla, Alok K.
    Rikhari, Pragya
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [4] The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system
    Cowen, MS
    Adams, C
    Kraehenbuehl, T
    Vengeliene, V
    Lawrence, AJ
    [J]. ADDICTION BIOLOGY, 2005, 10 (03) : 233 - 242
  • [5] Choosing Appropriate Anti-craving Pharmacotherapy for Alcohol and Opioid Use Disorder : A Psychopharmacological Approach
    Saha, Indranil
    Barua, Supartha
    Mondal, Arijit
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S165 - S165
  • [6] PHARMACOGENOMICS OF ACAMPROSATE AND NALTREXONE THERAPY RESPONSE IN ALCOHOL USE DISORDER (AUD)
    Zhu, X.
    Liu, D.
    Gao, H.
    Ho, M.
    Nguyen, T.
    Coombes, B.
    Biernacka, J.
    Karpyak, V.
    Weinshilboum, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S61 - S61
  • [7] Anti-craving medications for alcohol to treat moderate to severe alcohol use disorder
    Mong, Jon
    Ahamad, Keith
    Bach, Paxton
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (30) : E1196 - E1197
  • [8] Prescribing Pattern of Anti-Craving Drugs Among Alcohol Use Disorder Patients
    Dsouza, Prizvan Lawrence
    Krishna, Hattikuduru Vamsi
    Viswam, Subeesh Kulangara
    Singh, Hemendra
    [J]. ALCOHOLISM TREATMENT QUARTERLY, 2023, 41 (04) : 462 - 473
  • [9] Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder
    Ho, Ming-Fen
    Zhang, Cheng
    Moon, Irene
    Coombes, Brandon J. J.
    Biernacka, Joanna
    Skime, Michelle
    Choi, Doo-Sup
    Croarkin, Paul E. E.
    Frye, Mark A. A.
    Ngo, Quyen
    Skillon, Cedric
    Oesterle, Tyler S. S.
    Karpyak, Victor M. M.
    Li, Hu
    Weinshilboum, Richard M. M.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
    Ho, Ming-Fen
    Zhang, Cheng
    Wei, Lixuan
    Zhang, Lingxin
    Moon, Irene
    Geske, Jennifer R.
    Skime, Michelle K.
    Choi, Doo-Sup
    Biernacka, Joanna M.
    Oesterle, Tyler S.
    Frye, Mark A.
    Seppala, Marvin D.
    Karpyak, Victor M.
    Li, Hu
    Weinshilboum, Richard M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3330 - 3345
123